These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16002217

  • 21. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC, Muñoz-Fernández C, Alemany-Rodríguez MJ, del Carmen Pérez-Vieitez M, Aladro-Benito Y, Irurita-Latasa J, Sánchez-García F.
    Neurosci Lett; 2007 Oct 29; 427(1):34-8. PubMed ID: 17923322
    [Abstract] [Full Text] [Related]

  • 22. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
    Pola R, Flex A, Gaetani E, Proia AS, Papaleo P, Di Giorgio A, Straface G, Pecorini G, Serricchio M, Pola P.
    Exp Gerontol; 2004 Aug 29; 39(8):1249-52. PubMed ID: 15288699
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.
    Miyashita A, Arai H, Asada T, Imagawa M, Matsubara E, Shoji M, Higuchi S, Urakami K, Kakita A, Takahashi H, Toyabe S, Akazawa K, Kanazawa I, Ihara Y, Kuwano R, Japanese Genetic Study Consortium for Alzeheimer's Disease.
    Hum Mol Genet; 2007 Dec 01; 16(23):2854-69. PubMed ID: 17761686
    [Abstract] [Full Text] [Related]

  • 26. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
    Kamboh MI, Minster RL, Feingold E, DeKosky ST.
    Mol Psychiatry; 2006 Mar 01; 11(3):273-9. PubMed ID: 16302009
    [Abstract] [Full Text] [Related]

  • 27. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
    Poli M, Gatta LB, Lovati C, Mariani C, Galimberti D, Scarpini E, Biunno I, Musicco M, Dominici R, Albertini A, Finazzi D.
    Neurobiol Aging; 2008 Oct 01; 29(10):1494-501. PubMed ID: 17466415
    [Abstract] [Full Text] [Related]

  • 28. [Gender has a strong modulating effect on the risk of Alzheimer's disease conferred by the apolipoprotein E gene in the population of the Canary Islands, Spain].
    Déniz Naranjo MC, Muñoz Fernández C, Alemany Rodríguez MJ, Pérez Viéitez MC, Irurita Latasa J, Suárez Armas R, Suárez Valentín MP, Sánchez García F.
    Rev Neurol; 2008 Oct 01; 38(7):615-8. PubMed ID: 15098180
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
    Bray NJ, Jehu L, Moskvina V, Buxbaum JD, Dracheva S, Haroutunian V, Williams J, Buckland PR, Owen MJ, O'Donovan MC.
    Hum Mol Genet; 2004 Nov 15; 13(22):2885-92. PubMed ID: 15385439
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
    Licastro F, Chiappelli M, Grimaldi LM, Morgan K, Kalsheker N, Calabrese E, Ritchie A, Porcellini E, Salani G, Franceschi M, Canal N.
    Neurobiol Aging; 2005 Apr 15; 26(4):449-53. PubMed ID: 15653173
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients.
    Guidi I, Galimberti D, Venturelli E, Lovati C, Del Bo R, Fenoglio C, Gatti A, Dominici R, Galbiati S, Virgilio R, Pomati S, Comi GP, Mariani C, Forloni G, Bresolin N, Scarpini E.
    Neurobiol Aging; 2005 Jun 15; 26(6):789-94. PubMed ID: 15718036
    [Abstract] [Full Text] [Related]

  • 38. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
    Pesaresi M, Batelli S, Prato F, Polito L, Lovati C, Scarpini E, Quadri P, Mariani C, Albani D, Forloni G.
    Neurobiol Dis; 2007 Mar 15; 25(3):609-13. PubMed ID: 17174555
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.